openPR Logo
Press release

COVID-19 Impact on Dermatologicals Market to Grow $36 billion by 2026, at CAGR of 10.9% | Bayer AG, Johnson & Johnson, Pfizer Inc

08-10-2020 08:04 AM CET | Health & Medicine

Press release from: Allied Market Research

Dermatological Market

Dermatological Market

The global dermatologicals market was valued at $15 billion in 2018, and is expected to reach $36 billion by 2026, registering a CAGR of 10.9% from 2019 to 2026.

Global Dermatologicals Market Report provides an overview of the market based on key parameters such as market size, sales, sales analysis and key drivers. The market size of the market is expected to grow on a large scale during the forecast period (2019-2026). This report covers the impact of the latest COVID-19 on the market. The coronavirus epidemic (COVID-19) has affected all aspects of life around the world. This has changed some of the market situation. The main purpose of the research report is to provide users with a broad view of the market. Initial and future assessments of rapidly changing market scenarios and their impact are covered in the report.

Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/3805

Dermatologicals are the drugs that are used to treat or prevent conditions related to the skin. Moreover, dermatological preparations are applied directly to the skin by topical application or are administered through the parenteral route. Furthermore, dermatlogicals are also taken through oral route to cure skin conditions. Some of the conditions which are treated using dermatologicals include psoriasis, rosacea, acne, and dermatitis. For instance, psoriasis is a medical condition that leads to build up of skin cells causing discomfort to a patient. Therefore, dermatlogicals play a significant role in treatment of skin disorders.

Rise in demand for topical dermatological drugs, such as anti-inflammatory agents, anti-infective, local anesthetics, cleansers, and emollients to treat acne is the major factor that contributes to the growth of the dermatologicals market. Moreover, surge in awareness about skin diseases, high demand for rapid diagnosis, and surge in incidence of skin cancer & other skin disorders are the factors that boost the growth of the dermatologicals market. However, lack of awareness about drugs and stringent government regulations restrain the market growth. The development of innovative products and increase in numbers of mergers & acquisitions by key vendors are expected to provide numerous opportunities for the dermatologicals market growth during the forecast period.

The dermatologicals market size is studied on the basis of segments, dermatological disease, drug type, route of administration, and region to provide a detailed assessment of the market. On the basis of dermatological disease, it is segmented into acne, dermatitis, psoriasis, skin cancer, rosacea, alopecia, and others. Based on drug type, it is bifurcated into prescription-based drugs and over-the-counter drugs. On the basis of route of administration, it is segmented into topical, oral, and parenteral administration. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

According to dermatological disease, psoriasis occupied the largest dermatologicals market share in 2018. Furthermore, psoriasis segment is also the fastest growing segment during the forecast period. The growth of the segment is attributable to surge in the incidence of psoriasis worldwide. Furthermore, rise in awareness related to the use of topical ointments for the management and treatment of psoriasis is another major factor that drives the growth of the dermatologicals market.

By drug type, the prescription segment occupied the largest share, owing to surge in skin disorders. Furthermore, skin disorders are severe and require skilled medical attention, which is provided by skin specialists. Moreover, over-the-counter drugs is expected to be the fastest growing segment during the forecast period due to surge in the awareness among general public regarding the availability of dermatologicals.

By region, North America accounted for the major dermatologicals market share in 2018 and is expected to continue this trend, owing to easy availability of dermatologicals. Moreover, surge in the incidence of skin disorders such as dermatitis, acne, and psoriasis, is another major reason that contributes to the growth of this market. On the other side, Asia-Pacific is estimated to register the fastest growth during the forecast period attributed to the increase in awareness regarding the use of dermatologicals.

The developing economies offer lucrative opportunities for dermatological providers to expand their business. The constantly evolving life science industry drives the growth of the market in the developing economies such as India, China, and others. As the constant development leads to surge in awareness related to the use of dermatologicals. Furthermore, it also leads to rise in aesthetic consciousness among people which contributes to the growth of the market.

Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/3805

The Major Key Players Are:

collaboration, product launch, partnership, and acquisition. Major players operating in the market include Bayer AG, Johnson & Johnson, Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca, Galderma S.A., Amgen Inc., AbbVie Inc., and Merck KGaA.

Key Findings of the Study:

• Prostate cancer checks occupied two-fifth share of the global dermatologicals market in 2018.
• The psoriasis segment is anticipated to grow with the highest CAGR throughout the forecast period.
• The prescription-based drugs segment accounted for more than two-thirds share of the market in 2018.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

Contact:

David Correa
Portland, OR, United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COVID-19 Impact on Dermatologicals Market to Grow $36 billion by 2026, at CAGR of 10.9% | Bayer AG, Johnson & Johnson, Pfizer Inc here

News-ID: 2107810 • Views: 440

More Releases from Allied Market Research

Breast Biopsy Devices Market will be Dominate in coming years 2020-2023 With Ind …
Global breast biopsy market was valued at $977 million in 2016, and is projected to reach at $1,420 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. Core needle biopsy (CNB) segment accounted for about half of the global market share in 2016. Request Sample Report at:https://www.alliedmarketresearch.com/request-sample/1067 The major factors that boost the market growth include rise in incidence of breast cancer, growth in awareness toward cancer screening
Brain Health Supplements Market – Know Latest Trends & Forecast for Long-Term …
UPDATE AVAILABLE ON-DEMAND Brain health supplements are balanced blend of herbal extracts and nutrients that are used to improve brain functions such as concentration, focus, and memory. The global brain health supplements market was valued at $3,194 million in 2016, and is expected to reach $5,813 million by 2023, growing at a CAGR of 8.8% from 2017 to 2023. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/4581 Rise in awareness about brain health supplements, growth in number
Apheresis Market to High trend Opportunities offers Future Business Growth by 20 …
UPDATE AVAILABLE ON-DEMAND According to the report by Allied Market Research, the global Apheresis market is estimated to register a CAGR of 7.3% from 2017 to 2023. The research helps leading players and startups to devise new strategies based on current market trends and changing dynamics. Competitive landscape is mentioned in the report based on business segments, products portfolio, and strategic moves & developments of leading market players. Detailed segmentation assists
Medical Computer Carts Market New Business Opportunities and Investment Research …
UPDATE AVAILABLE ON-DEMAND According to the research report published by Allied Market Research, the global Medical Computer Carts market is expected to register a CAGR of 17.3% from 2017 to 2023. The research includes changing market dynamics, top impacting factors, key investment pockets, value chain, and competitive scenario. Through tabular and graphical representation, the report offers key insights on different aspects of the market such as current market size and estimations,

All 5 Releases


More Releases for Dermatological

“Global Dermatological Drugs Market Set to Grow To $36bn by 2024,” according …
Visiongain has launched a new pharma report Top 25 Dermatological Drugs Manufacturers 2019: Galderma, Johnson & Johnson, AbbVie, GlaxoSmithKline, Pfizer, Novartis, Eli Lilly, Mylan and other Companies. Dermatological drugs market has been growing over the last decade. A combination of significant new market launches and corporate activities has changed the outlook of the pharmaceutical industry towards this market. The dermatological drugs market in 2018 was reported to be US$ 26.23bn.
Dermatological Disorders Medications Market Size, Share, Development by 2024
New report published by Global Info Research which offers insights on the Global Dermatological Disorders Medications market. Dermatology diseases includes common skin rashes to severe skin infections, which occurs due to range of things, such as infections, heat, allergens, system disorders and medications. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-dermatological-disorders-medications-market_p103576.html Global Dermatological Disorders Medications Market: Forecast by Type / Application / Region The worldwide market for Dermatological Disorders Medications is
Dermatological Drugs Market Production, Sales, Consumption and Growth by 2025
HTF MI released a new market study on Global Dermatological Drugs Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates
Global Dermatological Therapeutics Sales Market Insights & Development Status Re …
A fresh report has been added to the wide database of Market Research Hub (MRH). The research study is titled “Global Dermatological Therapeutics Sales Market Report 2018” which encloses important data about the production, consumption, revenue and market share, merged with information related to the market scope and product overview. The report anticipates that the market for Dermatological Therapeutics would rise at a positive CAGR during the period 2018-2025. Report
Global Dermatological Diagnostics And Therapeutics Market Industry Analysis, Mar …
"The Report Dermatological Diagnostics And Therapeutics Market - Global Industry Analysis, Market Size, Market Share And Forecasts, 2012 - 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​The Dermatological diagnostics and therapeutics market is expected to grow steadily during the forecast period driven by increase in psoriasis market that is expected to boost competition among the existing products with more emerging
Global Dermatological Devices Market
The Global Dermatological Devices Market was valued at US$ 6,565.5 million in 2015 and is projected to expand at a CAGR of 7.6% during the forecast period (2016–2024),as highlighted in a new report published by Coherent Market Insights.Rise in number of patients suffering from non-melanoma and melanoma skin cancers is expected to be one of the major factor to drive the dermatology devices market in the near future. According to